Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

This study is ongoing, but not recruiting participants.

Study NCT00016263 Information provided by National Cancer Institute (NCI)

First Received: May 6, 2001 Last Updated: April 4, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given